Regencell Bioscience Market Sentiment

Market sentiment signals for Regencell Bioscience (RGC): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus— N/A

Short Interest▲ 1.2% short float

Options Flow▲ 0.01 P/C ratio

Insider Activity— N/A

Analyst Consensus

—

Options Flow (P/C)

0.01

More calls — Bullish

89 calls · 1 puts

Avg Consensus PT

—

Highest Price Target

—

Lowest Price Target

—

Short Interest

1.2%

Declining — Bullish

Insider Activity (30d)

—

Short Interest — % of Float

Insider & Market Activity News

Stocks That Hit 52-Week Lows On Wednesday

On Wednesday, 155 companies set new 52-week lows.

Benzinga Insights

PRO
Regencell Bioscience Holdings Limited Announces Over $5M Ordinary Share Purchases By CEO

Regencell Bioscience Holdings Limited (NASDAQ:RGC) (“Regencell” or the “Company”), an early-stage bioscience company focusing on the research, development and commercialization of Traditional

Benzinga Newsdesk

Regencell Bioscience Holdings Highlights $1M Share Purchase By CEO

Bill Haddad

Regal Ent Option Alert: Dec 15 $17.5 Calls Sweep (17) at the Bid: 553 @ $2.918 vs 21209 OI; Ref=$20.49

Benzinga

Regal Ent Option Alert: Dec 15 $17.5 Calls Sweep (27) at the Ask: 500 @ $1.351 vs 20921 OI; Ref=$16.99

Benzinga

Regal Ent Option Alert: Dec 15 $17.5 Calls Sweep (31) at the Ask: 1247 @ $0.601 vs 10656 OI; Ref=$16.09

Benzinga

Regencell Bioscience Holdings Ltd